Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl4-induced liver cirrhosis

doi:10.3748/wjg.v12.i5.709

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3195)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

274

HTML

2432

Figures (1-7)

243

Tables (1-1)

246

Sum=3195

Feb 7, 2006 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Feb 7, 2006; 12(5): 709-715
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.709

Full Size Figure Download Figure

Figure 7 Effect of BN52021 on femoral arterial and portal venous pressure of cirrhotic rats 8 wk after vehicle or CCl₄ treatment. Values are mean±SD 5-6 min after introduction of BN52021. ^aP < 0.05 vs basal value.

Citation: Yang YP, Ma XM, Wang CP, Han J, Lu YY, Xiang Y, Su SH, Feng YY. Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl₄-induced liver cirrhosis. World J Gastroenterol 2006; 12(5): 709-715
URL: https://www.wjgnet.com/1007-9327/full/v12/i5/709.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i5.709